Sorrento and Researchers at Karolinska Institutet Have Signed a Research Collaboration Agreement on iPSC-Derived Dimeric Antigen Receptor-Modified Natural Killer (DAR-NK) Cells With The Vision to Bring “Off-The-Shelf" NK Cell-Based Cancer Treatments Rapidly to Patients SAN DIEGO and STOCKHOLM, Sweden, June 04, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that the Company has entered into an additional...

Tymidinkinas 1 kan användas för tidigt terapisvar vid behandling av bröstcancer Patienter behandlade med Epirubicin och Docetaxel före operationen följdes med deras tymidinkinas (TK1) nivåer i blodet för att direkt observera behandlingssvaret. Resultaten visar att en TK1-baserat...

Thymidine Kinase 1 can be used for early detection of therapy response in breast cancer treatment Patients treated with Epirubicin and Docetaxel before surgery were followed by their thymidine kinase (TK1) levels in blood to directly observe treatment response. The results show that a TK1-based...

Feinstein Institute Presents Cerami Award to Karolinska Institutet Researcher MANHASSET, N.Y., Sept. 5, 2014 (GLOBE NEWSWIRE) -- The Feinstein Institute for Medical Research and Molecular Medicine announced today that it will confer the second Anthony Cerami Award in...